Search Results - "RIZZO, J. Douglas"

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry by Gragert, Loren, Eapen, Mary, Williams, Eric, Freeman, John, Spellman, Stephen, Baitty, Robert, Hartzman, Robert, Rizzo, J. Douglas, Horowitz, Mary, Confer, Dennis, Maiers, Martin

“…The National Marrow Donor Program (NMDP) has increased the availability of suitable HLA-matched donors of bone marrow and cord blood, such that more than 90%…”
Get full text

Surviving the cure: long term followup of hematopoietic cell transplant recipients by Majhail, N S, Douglas Rizzo, J

“…Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of transplant survivors. However, long-term survival is challenged by…”
Get full text

Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults by Majhail, Navneet S., Mau, Lih-Wen, Chitphakdithai, Pintip, Denzen, Ellen M., Joffe, Steven, Lee, Stephanie J., LeMaistre, Charles F., Loberiza, Fausto, Parsons, Susan K., Repaczki-Jones, Ramona, Robinett, Pam, Douglas Rizzo, J., Murphy, Elizabeth, Logan, Brent, Le-Rademacher, Jennifer

“…Allogeneic hematopoietic cell transplantation (alloHCT) is a highly specialized procedure. We surveyed adult transplant centers in the United States (US) and…”
Get full text

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation by WINGARD, John R, MAJHAIL, Navneet S, SOCIE, Gerard, BRAZAUSKAS, Ruta, ZHIWEI WANG, SOBOCINSKI, Kathleen A, JACOBSOHN, David, SORROR, Mohamed L, HOROWITZ, Mary M, BOLWELL, Brian, DOUGLAS RIZZO, J

“…Allogeneic hematopoietic cell transplantation (HCT) is curative but is associated with life-threatening complications. Most deaths occur within the first 2…”
Get full text

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia by Saber, Wael, Opie, Shaun, Rizzo, J. Douglas, Zhang, Mei-Jie, Horowitz, Mary M., Schriber, Jeff

“…Approximately one-third of patients with an indication for hematopoietic cell transplantation (HCT) have an HLA-matched related donor (MRD) available to them…”
Get full text

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation by Armand, Philippe, Kim, Haesook T., Logan, Brent R., Wang, Zhiwei, Alyea, Edwin P., Kalaycio, Matt E., Maziarz, Richard T., Antin, Joseph H., Soiffer, Robert J., Weisdorf, Daniel J., Rizzo, J. Douglas, Horowitz, Mary M., Saber, Wael

“…Because the outcome of allogeneic hematopoietic cell transplantation (HCT) is predominantly influenced by disease type and status, it is essential to be able…”
Get full text

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning by Majhail, Navneet S., Brazauskas, Ruta, Rizzo, J. Douglas, Sobecks, Ronald M., Wang, Zhiwei, Horowitz, Mary M., Bolwell, Brian, Wingard, John R., Socie, Gerard

“…Risks of secondary solid cancers among allogeneic hematopoietic cell transplant (HCT) recipients who receive conditioning without total body irradiation are…”
Get full text

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill by Knight, Jennifer M., Costanzo, Erin S., Singh, Suraj, Yin, Ziyan, Szabo, Aniko, Pawar, Deepa S., Hillard, Cecilia J., Rizzo, J. Douglas, D’Souza, Anita, Pasquini, Marcelo, Coe, Christopher L., Irwin, Michael R., Raison, Charles L., Drobyski, William R.

“…Because medical illness is associated with increased inflammation and an increased risk for treatment-resistant major depressive disorder, anti-cytokine…”
Get full text

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors by HAHN, Theresa, MCCARTHY, Philip L, LOBERIZA, Fausto, MAZIARZ, Richard T, RIZZO, J. Douglas, JOFFE, Steven, PARSONS, Susan, MAJHAIL, Navneet S, HASSEBROEK, Anna, BREDESON, Christopher, GAJEWSKI, James L, HALE, Gregory A, ISOLA, Luis M, LAZARUS, Hillard M, LEE, Stephanie J, LEMAISTRE, Charles F

“…Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases…”
Get full text

Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients by Knight, Jennifer M, Rizzo, J Douglas, Logan, Brent R, Wang, Tao, Arevalo, Jesusa M G, Ma, Jeffrey, Cole, Steve W

“…Low socioeconomic status (SES) is associated with adverse outcomes among unrelated donor hematopoietic stem cell transplant (HCT) recipients, but the biologic…”
Get full text

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update by RIZZO, J. Douglas, SOMERFIELD, Mark R, RARICK, Mark U, REGAN, David H, LICHTIN, Alan E, HAGERTY, Karen L, SEIDENFELD, Jerome, BOHLIUS, Julia, BENNETT, Charles L, CELLA, David F, DJULBEGOVIC, Benjamin, GOODE, Matthew J, JAKUBOWSKI, Ann A

“…To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was…”
Get full text

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology by Arber, Daniel A, Borowitz, Michael J, Cessna, Melissa, Etzell, Joan, Foucar, Kathryn, Hasserjian, Robert P, Rizzo, J Douglas, Theil, Karl, Wang, Sa A, Smith, Anthony T, Rumble, R Bryan, Thomas, Nicole E, Vardiman, James W

“…- A complete diagnosis of acute leukemia requires knowledge of clinical information combined with morphologic evaluation, immunophenotyping and karyotype…”
Get full text

Centralized patient‐reported outcome data collection in transplantation is feasible and clinically meaningful by Shaw, Bronwen E., Brazauskas, Ruta, Millard, Heather R., Fonstad, Rachel, Flynn, Kathryn E., Abernethy, Amy, Vogel, Jenny, Petroske, Charney, Mattila, Deborah, Drexler, Rebecca, Lee, Stephanie J., Horowitz, Mary M., Rizzo, J. Douglas

“…BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) cures many patients, but often with the risk of late effects and impaired quality of life. The…”
Get full text

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer by RIZZO, J. Douglas, BROUWERS, Melissa, JAKUBOWSKI, Ann A, REGAN, David H, SOMERFIELD, Mark R, HURLEY, Patricia, SEIDENFELD, Jerome, ARCASOY, Murat O, SPIVAK, Jerry L, BENNETT, Charles L, BOHLIUS, Julia, EVANCHUK, Darren, GOODE, Matthew J

“…To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients…”
Get full text

Solid cancers after allogeneic hematopoietic cell transplantation by Rizzo, J. Douglas, Curtis, Rochelle E., Socié, Gérard, Sobocinski, Kathleen A., Gilbert, Ethel, Landgren, Ola, Travis, Lois B., Travis, William D., Flowers, Mary E.D., Friedman, Debra L., Horowitz, Mary M., Wingard, John R., Deeg, H. Joachim

“…Transplant recipients have been reported to have an increased risk of solid cancers but most studies are small and have limited ability to evaluate the…”
Get full text

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation by Bredeson, Christopher, LeRademacher, Jennifer, Kato, Kazunobu, DiPersio, John F., Agura, Edward, Devine, Steven M., Appelbaum, Frederick R., Tomblyn, Marcie R., Laport, Ginna G., Zhu, Xiaochun, McCarthy, Philip L., Ho, Vincent T., Cooke, Kenneth R., Armstrong, Elizabeth, Smith, Angela, Rizzo, J. Douglas, Burkart, Jeanne M., Pasquini, Marcelo C.

“…We conducted a prospective cohort study testing the noninferiority of survival of ablative intravenous busulfan (IV-BU) vs ablative total body irradiation…”
Get full text

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States by D'Souza, Anita, Fretham, Caitrin, Lee, Stephanie J, Arora, Mukta, Brunner, Janet, Chhabra, Saurabh, Devine, Steven, Eapen, Mary, Hamadani, Mehdi, Hari, Parameswaran, Pasquini, Marcelo C, Perez, Waleska, Phelan, Rachel A, Riches, Marcie L, Rizzo, J Douglas, Saber, Wael, Shaw, Bronwen E, Spellman, Stephen R, Steinert, Patricia, Weisdorf, Daniel J, Horowitz, Mary M

“…•We summarize hematopoietic cell transplantation activity in the United States in 2018.•Key findings include fewer autologous transplantations performed for…”
Get full text

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation by Landgren, Ola, Gilbert, Ethel S., Rizzo, J. Douglas, Socié, Gérard, Banks, Peter M., Sobocinski, Kathleen A., Horowitz, Mary M., Jaffe, Elaine S., Kingma, Douglas W., Travis, Lois B., Flowers, Mary E., Martin, Paul J., Deeg, H. Joachim, Curtis, Rochelle E.

“…We evaluated 26 901 patients who underwent allogeneic hematopoietic cell transplantation (HCT) at 271 centers worldwide to define patterns of…”
Get full text

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Pulsipher, Michael A., Chitphakdithai, Pintip, Miller, John P., Logan, Brent R., King, Roberta J., Rizzo, J. Douglas, Leitman, Susan F., Anderlini, Paolo, Haagenson, Michael D., Kurian, Seira, Klein, John P., Horowitz, Mary M., Confer, Dennis L.

“…Limited data are available describing donor adverse events (AEs) associated with filgrastim mobilized peripheral blood stem cell (PBSC) collections in…”
Get full text

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft- versus -host disease: low incidence of lower gastrointestinal tract disease by Drobyski, William R, Szabo, Aniko, Zhu, Fenlu, Keever-Taylor, Carolyn, Hebert, Kyle M, Dunn, Renee, Yim, Sharon, Johnson, Bryon, D'Souza, Anita, Eapen, Mary, Fenske, Timothy S, Hari, Parameswaran, Hamadani, Mehdi, Horowitz, Mary M, Rizzo, J Douglas, Saber, Wael, Shah, Nirav, Shaw, Bronwen, Pasquini, Marcelo

“…We conducted a phase 2 study in which patients undergoing allogeneic hematopoietic stem cell transplantation received tocilizumab in addition to standard…”
Get full text